Q2 Earnings Forecast for Clorox Issued By DA Davidson

The Clorox Company (NYSE:CLX - Free Report) - Stock analysts at DA Davidson issued their Q2 2025 EPS estimates for Clorox in a report released on Monday, November 4th. DA Davidson analyst L. Weiser forecasts that the company will post earnings per share of $1.27 for the quarter. DA Davidson has a "Neutral" rating and a $171.00 price objective on the stock. The consensus estimate for Clorox's current full-year earnings is $6.81 per share.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 earnings per share.

Other equities analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $144.00 to $151.00 and gave the company a "hold" rating in a research note on Friday, August 2nd. Barclays lifted their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research note on Friday. Wells Fargo & Company dropped their price objective on shares of Clorox from $135.00 to $130.00 and set an "underweight" rating for the company in a research note on Wednesday, July 10th. Citigroup lifted their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research note on Friday, October 11th. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $151.57.

Clorox Price Performance

Shares of NYSE CLX traded down $0.11 during midday trading on Tuesday, reaching $162.37. The stock had a trading volume of 1,160,027 shares, compared to its average volume of 1,243,407. The stock has a 50-day moving average of $161.75 and a 200-day moving average of $146.46. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a market capitalization of $20.10 billion, a price-to-earnings ratio of 56.57, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41. Clorox has a 12-month low of $125.46 and a 12-month high of $169.09.

Institutional Trading of Clorox

Several large investors have recently bought and sold shares of the stock. Insight Folios Inc grew its position in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock worth $358,000 after purchasing an additional 63 shares during the last quarter. Fiduciary Group LLC lifted its stake in Clorox by 0.4% during the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company's stock valued at $2,600,000 after acquiring an additional 72 shares during the period. GHP Investment Advisors Inc. lifted its stake in Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company's stock valued at $496,000 after acquiring an additional 72 shares during the period. SPC Financial Inc. lifted its stake in Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company's stock valued at $476,000 after acquiring an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV lifted its stake in Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock valued at $83,000 after acquiring an additional 75 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company's stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by company insiders.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. Clorox's payout ratio is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.